| CAS: | 130929-57-6 | |
| 分子式: | C14H15N3O5 | |
| 分子量: | 305.29 | |
| 英文名称: |
|
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 | ||||||||||||||||||||||||||||||||||||||||
| E794252 | MACKLIN | 恩他卡朋 | 10mM in DMSO | 337元/1ml; | 展开 | ||||||||||||||||||||||||||||||||||||||||
储存：-20°C 状态：液体 | |||||||||||||||||||||||||||||||||||||||||||||
| E0961 | TCI | Entacapone | >98.0%(T)(HPLC) | 1490元/1G; 4990元/5G; | 展开 | ||||||||||||||||||||||||||||||||||||||||
基本信息
技术规格
物性(参考值)
相关法规
| |||||||||||||||||||||||||||||||||||||||||||||
| 374228 | J&K | Entacapone | 98% | 1463元/50MG; 2915元/200MG; | 展开 | ||||||||||||||||||||||||||||||||||||||||
基本信息
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||
| C46622 | Alfa Aesar | Entacapone | 9326元/250mg; 23393元/1g; | 展开 | |||||||||||||||||||||||||||||||||||||||||
基本信息 Ref# 分子式 分子量 | |||||||||||||||||||||||||||||||||||||||||||||
| Y0001249 | Entacapone | European Pharmacopoeia (EP) Reference Standard | 1572.27元/ ; | 展开 | |||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. 生化/生理作用 Entacapone is a catechol-O-methyl transferase (COMT) inhibitor. Used in treatment of Parkinson′s disease, entacapone is administered with L-DOPA to inihibit COMT from converting L-DOPA into a compound that cannot cross the blood brain barrier. 包装 Unit quantity: 160 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||
| SML0654 | Sigma-Aldrich | Entacapone | ≥98% (HPLC) | 898.46元/10 MG; 3088.72元/50 MG; | 展开 | ||||||||||||||||||||||||||||||||||||||||
产品说明 应用 Entacapone has been used in high-performance bioaffinity chromatography. 包装 10, 50 mg in glass bottle 生化/生理作用 Entacapone acts predominantly in the intestine. It increases the bioavailability of levodopa. Levodopa is known to be associated with many complications such as motor fluctuations. COMT inhibitors have been used to overcome these adverse effects of levodopa by reducing its metabolism. Entacapone exhibits its inhibition action on COMT in the peripheral nervous system. 特点和优势 This compound is featured on the Dopamine and Norepinephrine Metabolism page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||
| 1235933 | USP | Entacapone | United States Pharmacopeia (USP) Reference Standard | 6206.86元/200 MG; | 展开 | ||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. 生化/生理作用 Entacapone is a catechol-O-methyl transferase (COMT) inhibitor. Used in treatment of Parkinson′s disease, entacapone is administered with L-DOPA to inihibit COMT from converting L-DOPA into a compound that cannot cross the blood brain barrier. 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||
m.cnreagent.com